AZN · Healthcare
Astrazeneca Plc
4/100
Smart-money confidence1 of 3 sources positive
Bearish — money moving out
No standout activity across the feeds we track.
Hedge funds
6
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$244.6B
Industry
Drug Manufacturers - General
Sector
Healthcare
Exchange
NYSE
About ASTRAZENECA PLC
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit,…
Who's behind the signal
Every informed buyer we can see on AZN, across all three feeds.
Hedge funds · 1
Gotham Asset Mgmt (Greenblatt)
Decreased −31%
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 10 on record
Disclosures from 2017-09-08 to 2021-12-01
The newest disclosure we hold for this stock is 2021-12-01.
That is the end of our data, not necessarily the end of the trading — our
bulk STOCK Act archive stops there and newer filings arrive through a
separate live feed. Treat the absence of recent rows as “not covered”,
not as “no trades”.
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2021-12-01 | Alan S. Lowenthal · D-CA | House | Sold | $1,001 - $15,000 |
| 2021-07-21 | Dean Phillips · D-MN | House | Bought | $1,001 - $15,000 |
| 2021-04-09 | Sara Jacobs · D-CA | House | Sold | $15,001 - $50,000 |
| 2021-02-22 | Alan S. Lowenthal · D-CA | House | Bought | $1,001 - $15,000 |
| 2021-02-22 | Alan S. Lowenthal · D-CA | House | Bought | $1,001+ |
| 2021-02-22 | Alan S. Lowenthal · D-CA | House | Bought | $15,001 - $50,000 |
| 2020-12-01 | Greg Gianforte · R-MT | House | Bought | $1,001 - $15,000 |
| 2020-01-15 | John H. Rutherford · R-FL | House | Sold | $1,001 - $15,000 |
| 2019-03-11 | Shelley Moore Capito · R-WV | Senate | Sold | $1,001 - $15,000 |
| 2017-09-08 | Shelley Moore Capito · R-WV | Senate | Bought | $1,001 - $15,000 |
Not a model pick — but on our radar.
ASTRAZENECA PLC isn't in the top-10 model right now, but 1 tracked investor holds it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
1
Investors
0
New positions
0
Increasing
1
Decreasing
0
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.1×
% of portfolio
0.0%
Position change
−31%
0.0% of Gotham Asset Mgmt's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to ASTRAZENECA PLC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell ASTRAZENECA PLC or any security.
Get the Weekly Update
Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime